Product Introduction Fulvestrant Injection 250mg/5mL is a sterile hormonal anticancer medicine used in the treatment of selected hormone receptor-positive breast cancers. It belongs to the estrogen receptor antagonist (SERD) class and works by blocking and reducing estrogen receptors that may promote the growth of certain breast cancer cells. Product Profile Specification Details Generic Name:Fulvestrant Strength:250mg/5mL Dosage Form:Sterile Injection Medicine Category:Hormonal Anticancer Medicine Drug Class:Selective Estrogen Receptor Degrader (SERD) Route of Administration:Intramuscular Injection Prescription Status:Prescription Only Primary Users:Hospitals & Oncology Centers Export Availability:Bulk & Commercial Supply Country of Origin: India In Case of Emergency or Overdose Seek immediate medical attention. Monitor the patient for worsening adverse effects and overall clinical condition. Supportive medical care should be provided based on symptoms. Inform the treating oncologist about the amount administered and the timing of the dose. Patients should never attempt to self-inject or adjust treatment schedules. Other Uses for This Medicine Besides its approved indications, healthcare professionals may consider Fulvestrant for certain specialized treatment strategies based on current clinical guidelines and patient-specific factors. In some cases, oncologists may combine it with other targeted anticancer medicines where clinically appropriate. What Side Effects Can This Medication Cause?: Frequently Reported Effects Injection-site discomfort Nausea Fatigue Headache Joint or muscle pain Mild weakness Unusual bleeding Persistent swelling of the legs Difficulty breathing or chest discomfort Global Demand for Hormonal Oncology Medicines Continues to Rise: Breast cancer treatment programs continue expanding worldwide, increasing procurement of hormone-based injectable medicines across North America, Europe, the Middle East, and Asia-Pacific. Frequently Asked Questions 1. What is Fulvestrant Injection 250mg/5mL primarily used for? It is prescribed for selected patients with hormone receptor-positive breast cancer as part of specialist-directed hormonal treatment. 2. Who should administer Fulvestrant Injection? Only qualified healthcare professionals should administer the injection in hospitals or oncology clinics. 3. Can hospitals order Fulvestrant Injection in bulk? Yes. Licensed hospitals, oncology centers, pharmaceutical distributors, and government procurement agencies may purchase commercial quantities subject to applicable regulations. 4. What export documents are generally available? Eligible international orders may include documents such as the Certificate of Analysis (COA), Certificate of Origin (COO), Commercial Invoice, Packing List, and other export-related documentation. 5. Why is India a preferred source for Fulvestrant Injection? India is recognized for high-quality pharmaceutical manufacturing, competitive pricing, scalable production capacity, and reliable international export support. -Buy Fulvestrant Injection 250mg 5mL Online -Fulvestrant Injection Supplier USA -Fulvestrant Exporter India -Hormonal Cancer Injection Supplier -Breast Cancer Medicine Export -Fulvestrant Wholesale Distributor -Oncology Injection Supplier -Injectable Breast Cancer Medicine -Pharmaceutical Export Company India -Hospital Oncology Procurement 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #FulvestrantInjection #Fulvestrant250mg #BreastCancerMedicine #HormonalTherapy #OncologyInjection #CancerCare #USAHealthcare #WashingtonDCMedical #HospitalProcurement #IndianPharmaExporter #GlobalPharma #BulkMedicineSupplier #HealthcareDistribution #OncologySupplier #MedicalExports #CancerTreatment #PharmaceuticalExporter #WorldwideHealthcare #LicensedMedicineSupplier #ErnestPharmaceutical

Affordable Bicalutamide 50mg Tablets Exporter Product Profile Feature Details Generic Medicine Bicalutamide Available Strength 50 mg Tablets Therapeutic Class Non-Steroidal Anti-Androgen Administration Oral Intended Users Hospitals, Oncology Clinics & Licensed Distributors Export Availability Bangkok (Thailand), Abu Dhabi (UAE) & Worldwide Clinical Role in Prostate Cancer Bicalutamide is prescribed to reduce the influence of male hormones (androgens) that contribute to prostate cancer growth. It is commonly introduced as part of hormone deprivation therapy and may be used alongside other approved treatments depending on the patient's clinical status. Patients Who May Receive This Medicine Healthcare professionals may prescribe Bicalutamide for: Hormone-sensitive prostate cancer Advanced or metastatic prostate cancer Combination treatment with GnRH/LHRH therapy Long-term endocrine management where clinically appropriate Treatment selection depends entirely on the oncologist's evaluation. Expected Treatment Benefits Patients receiving appropriate therapy may benefit from: Suppression of androgen activity Slower progression of hormone-dependent prostate cancer Oral tablet convenience without injection Compatibility with several established prostate cancer treatment protocols Long-term disease management under medical supervision If Too Many Tablets Are Taken An excessive amount of Bicalutamide may increase the possibility of unwanted reactions such as weakness, dizziness, stomach discomfort, or abnormal liver function. Patients should immediately contact a physician or poison centre if an overdose is suspected. There is no specific reversal medicine, therefore treatment generally focuses on observation and supportive care according to the patient's condition. Why Pharmaceutical Buyers Prefer Indian Supply Indian manufacturers continue supplying international markets because they offer: ✓ Consistent manufacturing quality ✓ GMP production facilities ✓ Commercial export quantities ✓ Competitive international pricing ✓ Documentation for regulated markets ✓ Reliable shipment scheduling FAQs 1. Can distributors order commercial quantities? Yes. Bulk supply is available for licensed pharmaceutical businesses. 2. Is Bicalutamide supplied in tablet form? Yes. This product is supplied as oral tablets. 3. Can hospitals request quotations? Yes. Commercial quotations are available for hospitals and procurement agencies. 4. Does every patient receive the same treatment plan? No. Therapy is individualized according to the treating oncologist. 5. Can exporters provide shipment documentation? Yes. Commercial export documents are provided according to destination-country requirements. 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Distributor | Bulk Supplier | Exporter 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #Bicalutamide50mg #HormonalOncology #ProstateCancerDrug #AntiAndrogenTherapy #GenericCancerMedicine #HospitalMedicine #BulkPharmaceuticals #GlobalDrugSupply #MedicineExporterIndia #WHOPharma #CancerTabletSupplier #BangkokHealthcare #UAEPharma #OncologyDistribution Generic Bicalutamide Manufacturer Bicalutamide 50mg Export Supplier Anti-Androgen Tablet Export Prostate Cancer Drug Manufacturer Oncology Tablet Wholesaler Pharmaceutical Export from India Hormonal Therapy Medicine Supplier Hospital Cancer Medicine Distributor Bicalutamide Commercial Supply

PRIMOXX 100 10ML Injection – Product Information Guide Description Learn about PRIMOXX 100 10ML Injection, containing Methenolone Enanthate 100mg/ml, including product profile, clinical-use overview, precautions, side effects, storage guidance, and regulatory information. PRIMOXX 100 10ML Injection PRIMOXX 100 10ML Injection contains Methenolone Enanthate 100mg/ml, an injectable anabolic-androgenic steroid formulation intended for use only under qualified medical supervision. It is administered by intramuscular route when prescribed by a healthcare professional for approved or clinically justified medical purposes. Key Product Information Brand Name: PRIMOXX 100 Generic Name: Methenolone Enanthate Strength: 100mg/ml Pack Size: 10ml Vial Dosage Form: Injection Therapeutic Category: Anabolic-Androgenic Steroid Route of Administration: Intramuscular Use: Prescription-based medical use only Clinical Indications & Usage Certain wasting or muscle-loss conditions Supportive anabolic therapy where clinically justified Selected cases requiring specialist-supervised anabolic support Other physician-determined medical needs Mechanism of Action: How PRIMOXX 100 Works Step-by-Step Action The injection is administered intramuscularly by a qualified professional. Methenolone Enanthate is gradually released into the bloodstream. The active compound interacts with androgen receptors. Protein metabolism and anabolic pathways may be influenced. Clinical response is monitored by a healthcare provider. Treatment is adjusted or stopped based on safety and medical need. Administration and Dosing Guide ministration Use only as prescribed by a qualified healthcare professional. Administration should be performed by trained medical personnel. Do not self-administer unless specifically trained and advised. Do not exceed the prescribed dose or treatment duration. Missed Dose If a scheduled dose is missed, contact the prescribing healthcare provider. Do not take an extra dose or change the schedule without medical advice. Safety, Side Effects, and Monitoring ommon Side Effects Acne or oily skin Fluid retention Headache Mood changes Changes in libido ossible Serious Side Effects Seek medical attention if any of the following occur: Severe allergic reaction Breathing difficulty Chest pain Possible Serious Side EffectsBreathing difficulty Chest pain Significant swelling Precautions: Before using PRIMOXX 100, inform your doctor if you have: Liver disease Heart disease Kidney problems High blood pressure Cholesterol abnormalities Hormonal disorders Prostate-related conditions History of mood disorders Any ongoing medication use Storage and Handling Specifications tore as per the product label instructions. Keep away from excessive heat, moisture, and direct sunlight. Keep the vial in original packaging until use. Do not freeze unless stated on the label. Keep out of reach of children. Regulatory and Compliance Documentation Certificate of Analysis, if available Product specifications Batch details Invoice and export documentation Manufacturer-related documents Quality and compliance records PRESCRIPTION MEDICINE IS : YES Disclaimer: PRIMOXX 100 10ML Injection is a prescription-only medicine and should be used only under qualified medical supervision. Product availability, usage, import/export, and documentation depend on local laws and regulatory requirements. This information is for educational and product reference purposes only and is not medical advice. Frequently Asked Questions 1. What is PRIMOXX 100 10ML Injection? : PRIMOXX 100 10ML Injection is an injectable product containing Methenolone Enanthate 100mg/ml. 2. What is methenolone enanthate? Methenolone enanthate is an anabolic-androgenic steroid compound used only under medical supervision where clinically appropriate. 3. Can PRIMOXX 100 be used without a prescription? : No. This product should be used only with valid medical guidance and according to local laws and prescription requirements. 4. Is PRIMOXX 100 used for bodybuilding? : PRIMOXX 100 should not be used for bodybuilding, athletic enhancement, or self-medication. Misuse of anabolic steroids can cause serious health risks. 5. How is PRIMOXX 100 administered? : It is intended for intramuscular administration by a qualified healthcare professional. Contact Ernest Oncology—Pharmaceutical Exporter Group of Ernest Pharmaceutical Pvt. Ltd. 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/91935990238

ZODLIEVA 4 mg Injection (Zoledronic Acid): The Gold Standard in Bone Health and Supportive Oncology ZODLIEVA 4 mg Injection is a high-potency bisphosphonate containing the active pharmaceutical ingredient Zoledronic Acid (often referred to as Zoledronate). It is a critical supportive care medication used globally to manage and prevent skeletal-related events in patients with advanced malignancies. By targeting bone metabolism, ZODLIEVA 4mg helps preserve skeletal integrity, reduce bone pain, and manage life-threatening electrolyte imbalances. Therapeutic Indications and Clinical Applications Bone Metastases from Solid Tumors: Indicated for patients with advanced cancers (such as breast, prostate, or lung cancer) that have spread to the bone, helping to prevent fractures and spinal cord compression. Multiple Myeloma: Used to treat bone lesions and prevent skeletal complications in patients diagnosed with plasma cell dyscrasias. Hypercalcemia of Malignancy (HCM): A life-saving intervention used to rapidly reduce and stabilize dangerously high calcium levels in the blood caused by tumor activity. Osteoporosis Management: In certain clinical settings, it is used to increase bone mass and reduce the risk of fractures in high-risk patients. Mechanism of Action: How ZODLIEVA 4mg Works Cytoskeletal Disruption: This blockade disrupts the internal structure of the osteoclast, causing it to lose its ability to resorb bone. Apoptosis: The drug ultimately triggers programmed cell death (apoptosis) in overactive osteoclasts. Mineral Retention: By stopping excessive bone breakdown, ZODLIEVA prevents the release of calcium into the bloodstream and strengthens the bone matrix. Professional Administration and Dosage Route: Administered strictly via Intravenous (IV) Infusion. Infusion Duration: The 4mg dose must be administered over at least 15 minutes. Rapid infusion can significantly increase the risk of renal toxicity. Hydration: Patients must be adequately hydrated before and after administration to protect kidney function. Frequency: For bone metastases, it is typically administered once every 3 to 4 weeks, or as directed by the oncologist. Safety Profile and Clinical Oversight Renal Function: Serum creatinine levels must be checked before every dose. Dosage adjustments are required for patients with mild to moderate renal impairment. Electrolyte Levels: Monitoring of serum calcium, phosphate, and magnesium is essential to prevent hypocalcemia. Oral Health (ONJ): Patients should undergo a dental exam before starting treatment, as bisphosphonates are linked to a rare condition called Osteonecrosis of the Jaw (ONJ). Acute Phase Reaction: Some patients may experience “flu-like“ symptoms (fever, muscle pain, fatigue) within the first three days of the initial infusion. Why Choose Ernest Oncology? 100% Authentic Supply: We source ZODLIEVA directly from GMP-certified facilities, ensuring product integrity and long shelf life. Global Logistics Network: We provide rapid and secure shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, the Middle East, Africa, and Asia. Regulatory Documentation: Every shipment includes the necessary Certificates of Analysis (CoA) and export documentation for hassle-free customs clearance. Wholesale Bulk Supply: We offer competitive pricing models for oncology hospitals, clinics, and government health departments worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestimpex.com www.ernestvision.com 📧 Email: [exports@ernestpharmaceuticals.com] 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection

Laviat 5 mg Capsule (Lenalidomide): Precision Immunotherapy for Long-Term Oncology Care Laviat 5 mg Capsule is a high-efficacy, low-dose immunomodulatory medication featuring the active pharmaceutical ingredient Lenalidomide. Classified as an immunomodulatory imide drug (IMiD), the 5 mg strength is a vital therapeutic tool used primarily for maintenance therapy, precise dose titration, and treatment regimens for patients with specific renal considerations. Manufactured by Fresenius Kabi Oncology Ltd., Laviat 5mg provides a strategic balance between controlling malignant cell proliferation and maintaining a high quality of life for the patient. Therapeutic Indications and Clinical Usage Laviat 5mg is integrated into global oncology protocols for the management of: Multiple Myeloma (MM) Maintenance: Used as a long-term strategy following autologous stem cell transplant (ASCT) to prolong progression-free survival and prevent disease relapse. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Used for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma (FL): Often used in combination with Rituximab for adult patients previously treated for follicular or marginal zone lymphoma. Mechanism of Action: How Laviat 5mg Works Cereblon Binding: It binds to the protein Cereblon, a component of the E3 ubiquitin ligase complex, leading to the targeted degradation of transcription factors required for cancer cell survival. Immune System Activation: It stimulates T-cells and Natural Killer (NK) cells, significantly increasing the body's natural ability to identify and eliminate tumor cells. Anti-Angiogenesis: It inhibits the development of new blood vessels (angiogenesis) that tumors require for oxygen and nutrient supply. Cytokine Regulation: It suppresses the production of pro-inflammatory cytokines such as TNF-$alpha$ and IL-6, which are known to promote the growth of myeloma cells in the bone marrow microenvironment. Dosage and Administration GuidelinesMaintenance Regimen: The 5 mg dose is frequently taken once daily, often on a cycle of “21 days on, 7 days off“ or as a continuous daily dose depending on the protocol. Administration: Capsules must be swallowed whole with water. Do not open, crush, or chew them. Consistency: Can be taken with or without food, but should be taken at a consistent time each day to maintain steady-state plasma levels. Dose Flexibility: The 5 mg strength allows oncologists to de-escalate dosage from 25 mg or 15 mg strengths to manage hematological toxicities effectively. Safety Profile and Clinical Monitoring Medical supervision is mandatory while taking Laviat 5mg: Hematological Vigilance: Regular Complete Blood Counts (CBC) are necessary to monitor for neutropenia (low white blood cells) and thrombocytopenia (low platelets). Thromboembolism Prophylaxis: There is an increased risk of blood clots (DVT/PE). Most patients are prescribed concurrent anticoagulants (blood thinners). Embryo-Fetal Toxicity (REMS): Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients regardless of the dose. Common Side Effects: Fatigue, diarrhea, muscle cramps, and skin rashes are frequently reported and managed with supportive care. Storage and Global Handling Instructions Temperature: Store at room temperature, 20°C to 25°C. Protection: Keep capsules in the original blister packaging to protect from light and moisture. Safety: Caregivers should avoid direct skin contact with the medication; if a capsule is broken, wash the area immediately with soap and water. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Lenmid 5mg Capsule (Lenalidomide): Precision Maintenance Therapy for Hematological Oncology Lenmid 5mg Capsule is a specialized, low-dose immunomodulatory medication containing the active pharmaceutical ingredient Lenalidomide. Classified as an immunomodulatory imide drug (IMiD), the 5 mg strength is a cornerstone of long-term cancer management. It is primarily utilized for maintenance therapy and dose-adjusted regimens for patients requiring a balanced approach between clinical efficacy and toxicity management. Manufactured by Cipla, a global pharmaceutical leader, Lenmid 5mg is essential for sustaining remission in various blood-related malignancies. Therapeutic Indications and Clinical Usage Lenmid 5mg is utilized across major international oncology protocols for: Multiple Myeloma (MM) Maintenance: Following an autologous stem cell transplant (ASCT) or induction therapy, the 5 mg dose is the standard for long-term maintenance to prevent disease recurrence. Myelodysplastic Syndromes (MDS): Specifically indicated for transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Used as a treatment for patients whose disease has relapsed or progressed after at least two prior therapies. Renal Dose Adjustments: For patients with moderate-to-severe renal impairment, the 5 mg capsule allows for precise titration to maintain therapeutic levels without overwhelming the kidneys. Mechanism of Action: How Lenmid 5mg Works Immune System Modulation: It enhances the activity of T-cells and Natural Killer (NK) cells, significantly boosting the body's innate ability to identify and destroy residual cancer cells. Anti-Angiogenesis: It inhibits the secretion of pro-angiogenic factors (like VEGF), effectively blocking the formation of new blood vessels that tumors need to grow. Direct Tumoricidal Activity: It induces cell cycle arrest and triggers apoptosis (programmed cell death) specifically in malignant hematopoietic cells. Cytokine Regulation: It suppresses the production of pro-inflammatory cytokines such as TNF-$alpha$ and IL-6, which are known to promote the growth of myeloma cells. Dosage and Administration Guidelines Maintenance Protocol: In maintenance settings, Lenmid 5 mg is typically taken once daily, often on a “21 days on, 7 days off“ cycle or as a continuous daily dose. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Timing: Can be taken with or without food, but should be taken at a consistent time each day to maintain steady-state plasma concentrations. Professional Titration: Oncologists may adjust the dose from higher strengths (25 mg or 15 mg) down to 5 mg based on patient tolerance and hematological response. Safety Profile and Clinical Monitoring Due to its immunomodulatory nature, Lenmid 5 mg requires consistent medical oversight: Hematological Monitoring: Regular Complete Blood Counts (CBC) are mandatory to monitor for neutropenia (low white blood cells) and thrombocytopenia (low platelets). Thromboembolism Prophylaxis: There is an increased risk of blood clots (DVT/PE). Most patients are prescribed concurrent blood thinners (anticoagulants) such as aspirin or warfarin. Embryo-Fetal Toxicity (REMS): Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients regardless of the dose. Common Side Effects: Fatigue, diarrhea, muscle cramps, and skin rashes are frequently reported and managed with supportive care. Storage and Global Handling Instructions Temperature: Store at room temperature, 20°C to 25°C. Original Packaging: Keep capsules in the original blister pack to protect them from moisture and light. Safety: Caregivers should handle the capsules with care; avoid skin contact if a capsule is accidentally broken. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Carfizome 60mg Injection (Carfilzomib): Targeted Proteasome Inhibition for Advanced Multiple Myeloma. Carfizome 60mg Injection is a high-potency antineoplastic biological therapy featuring the active pharmaceutical ingredient Carfilzomib. As a second-generation proteasome inhibitor, Carfizome 60mg represents a major clinical advancement in the treatment of plasma cell malignancies. It is specifically engineered to provide a more targeted, irreversible binding mechanism compared to first-generation inhibitors, ensuring a deeper and more durable clinical response for patients with relapsed or refractory disease. Therapeutic Indications and Clinical Usage Carfizome 60mg is a cornerstone in international oncology protocols for: Relapsed or Refractory Multiple Myeloma (RRMM): Indicated for adult patients who have received at least one to three prior lines of therapy. Combination Regimens: Frequently prescribed in synergy with Dexamethasone or a combination of Lenalidomide and Dexamethasone to maximize progression-free survival (PFS). Targeted Intervention: It is the preferred choice for patients who have shown resistance to earlier proteasome inhibitors like bortezomib, offering a path forward in complex treatment journeys. Mechanism of Action: How Carfizome 60mg Works Irreversible Proteasome Blockade: Carfilzomib binds irreversibly to the 20S proteasome, the enzyme complex responsible for degrading unwanted or damaged proteins within the cell. Proteotoxic Stress: By blocking this “waste disposal“ system, Carfizome causes a rapid, toxic buildup of polyubiquitinated proteins. Induction of Apoptosis: This internal protein overload triggers a massive cellular stress response, leading directly to apoptosis (programmed cell death) in malignant plasma cells. Selective Potency: Because myeloma cells produce large volumes of antibodies (proteins), they are uniquely sensitive to this mechanism, allowing for targeted destruction with minimized damage to healthy cells. Dosage and Administration Guidelines Administration: Carfizome 60mg is administered strictly as an intravenous (IV) infusion by clinical professionals. Infusion Duration: The procedure typically takes between 10 to 30 minutes, depending on the specific cycle and patient tolerance. Cycle Schedule: Administered in 28-day cycles, usually on two consecutive days each week for three weeks, followed by a 12-day rest period. Hydration Protocol: Adequate hydration (both oral and IV) is mandatory before and after the dose to protect kidney function and prevent Tumor Lysis Syndrome (TLS). Safety Profile and Professional Monitoring Treatment with Carfizome 60mg requires consistent medical oversight for: Cardiac and Pulmonary Health: Monitoring for signs of heart failure, hypertension, or acute respiratory distress. Renal Monitoring: Regular serum creatinine checks are vital to ensure the kidneys are processing the medication effectively. Hematological CBC: Periodic blood counts are necessary to monitor for potential thrombocytopenia (low platelets) or anemia. Common Side Effects: Fatigue, nausea, fever, and headache are frequently reported and managed with supportive care. Strict Cold-Chain Storage & Global Handling Temperature Sensitivity: Carfizome is a biological product and MUST be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Light Protection: Vials should be kept in the original carton to prevent degradation from light exposure. Global Transit Security: For international export, specialized thermal packaging and real-time temperature loggers are used to ensure the medication remains potent and safe during transit to the USA, UK, UAE, Australia, and beyond. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Carzomib 60mg Injection (Carfilzomib): Advanced Proteasome Inhibition for Relapsed Multiple Myeloma. Carzomib 60mg Injection is a high-potency antineoplastic biological therapy featuring the active ingredient Carfilzomib. Classified as a second-generation proteasome inhibitor, Carzomib is a vital therapeutic intervention for patients diagnosed with multiple myeloma. Manufactured by Hetero Healthcare, one of India’s most trusted pharmaceutical giants, Carzomib 60mg is engineered to provide a more targeted, irreversible binding mechanism that enhances anti-tumor activity while offering a manageable safety profile. Therapeutic Indications and Clinical Usage Carzomib 60mg is utilized globally in advanced oncology settings for: Relapsed or Refractory Multiple Myeloma (RRMM): Specifically for adult patients who have received at least one to three prior lines of therapy. Combination Regimens: Often used in combination with Dexamethasone or a combination of Lenalidomide and Dexamethasone to improve progression-free survival (PFS). Targeted Intervention: It is preferred for patients who have shown resistance to first-generation proteasome inhibitors like bortezomib. Mechanism of Action: How Carzomib 60mg Works Proteasome Blockade: Carfilzomib binds irreversibly to the 20S proteasome, the enzyme complex responsible for degrading unwanted or damaged proteins within the cell. Protein Accumulation: By inhibiting this “waste disposal“ system, Carzomib causes a rapid, toxic buildup of polyubiquitinated proteins. Programmed Cell Death: This internal protein overload triggers a massive cellular stress response, leading directly to apoptosis (cell death) in malignant plasma cells. Irreversible Binding: Unlike earlier treatments, the irreversible nature of Carzomib ensures a more prolonged and potent suppression of tumor growth. Dosage and Administration Guidelines Administration: Carzomib 60 mg is administered strictly as an intravenous (IV) infusion by clinical experts. Infusion Duration: The procedure typically takes between 10 and 30 minutes, depending on the specific cycle and patient tolerance. Treatment Cycle: Administered in 28-day cycles, usually on two consecutive days each week for three weeks, followed by a 12-day rest period. Hydration Protocol: Adequate oral and IV hydration is mandatory before and after the dose to protect renal function and prevent Tumor Lysis Syndrome (TLS). Safety Profile and Professional Monitoring Cardiac & Pulmonary Health: Monitoring for signs of heart failure, hypertension, or acute respiratory distress. Renal Monitoring: Regular serum creatinine checks are vital to ensure the kidneys are processing the medication effectively. Hematological CBC: Periodic blood counts are necessary to monitor for potential thrombocytopenia (low platelets) or anemia. Common Side Effects: Fatigue, nausea, fever, and headache are frequently reported and managed with supportive care. Strict Cold-Chain Storage & Global Handling Temperature Sensitivity: Carzomib is a biological product and MUST be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Light Protection: Vials should be kept in the original carton to prevent degradation from light exposure. Global Transit Security: For international export, we utilize validated thermal packaging and real-time temperature loggers to ensure the medication remains potent and safe during transit to the USA, UK, UAE, Australia, and beyond. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Kyprolis 60mg Injection (Carfilzomib): The Gold Standard Proteasome Inhibitor for Multiple Myeloma Kyprolis 60 mg Injection is a sophisticated antineoplastic agent containing the active substance Carfilzomib. As a second-generation proteasome inhibitor, Kyprolis is engineered for higher selectivity and more potent anti-tumor activity compared to earlier treatments. Manufactured by Amgen, it is a vital therapeutic intervention for patients with multiple myeloma, particularly those who have developed resistance to other therapies. Therapeutic Indications and Clinical Usage Kyprolis 60 mg is a cornerstone in international hematological oncology for the treatment of: Relapsed or Refractory Multiple Myeloma (RRMM): Specifically for adult patients who have received one to three prior lines of therapy. Combination Regimens: * Kd Regimen: Combined with Dexamethasone. KRd Regimen: Combined with Lenalidomide and Dexamethasone. DKd Regimen: Combined with Daratumumab and Dexamethasone. Superior Progression-Free Survival: Clinical trials have demonstrated that Kyprolis-based regimens significantly extend survival compared to standard-of-care treatments in relapsed settings. Mechanism of Action: How Kyprolis 60mg Works Irreversible Proteasome Binding: Carfilzomib binds irreversibly to the chymotrypsin-like activity of the 20S proteasome. Inhibition of Protein Degradation: The proteasome is the cell's “shredder“ for damaged proteins. Blocking it causes an immediate, toxic buildup of polyubiquitinated proteins. Induction of Apoptosis: Myeloma cells produce vast amounts of protein (M-protein); when their “waste disposal“ is blocked, they experience overwhelming cellular stress, leading to programmed cell death (apoptosis). Targeted Efficiency: Kyprolis is designed to minimize off-target binding, which is why it often presents a lower incidence of peripheral neuropathy compared to first-generation inhibitors like bortezomib. Dosage and Administration Guidelines Administration: Kyprolis 60 mg is administered strictly via intravenous (IV) infusion by clinical professionals. Infusion Time: Depending on the dose and regimen, infusions typically last 10 minutes or 30 minutes. Cycle Intensity: Usually administered on two consecutive days each week for three weeks, followed by a 12-day rest period (28-day cycle). Pre-Treatment Hydration: Adequate oral and IV hydration is mandatory before and after the first cycle to prevent Tumor Lysis Syndrome (TLS) and protect renal function. Safety Profile and Professional Monitoring Cardiac & Pulmonary Health: Monitoring for signs of heart failure, hypertension, or pulmonary hypertension. Renal Function: Regular serum creatinine monitoring is essential, as the medication is processed through the kidneys. Hematological CBC: Periodic blood counts are necessary to manage potential thrombocytopenia (low platelets) or anemia. Common Side Effects: Fatigue, nausea, fever, headache, and diarrhea are frequently reported and managed with supportive care. Strict Cold-Chain Storage & Global Handling Temperature Sensitivity: Kyprolis is a sensitive biologic and MUST be stored refrigerated between 2°C and 8°C (36°F to 46°F). Handling: Do not freeze the vial. Keep it in the original carton to protect it from light. Logistical Security: For global export, we utilize validated thermal packaging and real-time data loggers to ensure the medication remains within the required temperature range throughout transit. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383